Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Neosporin market share 30?

See the DrugPatentWatch profile for Neosporin

Neosporin's market share in the topical antibiotic ointment category is not publicly disclosed in a way that allows for a specific percentage like 30% to be confirmed. However, Neosporin is a widely recognized brand and a dominant player in the over-the-counter (OTC) antibiotic ointment market in the United States [1].

How strong is Neosporin's brand recognition?


Neosporin is a household name, often used synonymously with the product category itself. Its long-standing presence and extensive marketing have established it as a go-to option for minor cuts, scrapes, and burns, contributing to its significant market presence [1].

Who makes Neosporin?


Neosporin is manufactured by Johnson & Johnson Consumer Health Inc. [2].

What are the main ingredients in Neosporin?


The original formulation of Neosporin contains three active ingredients: bacitracin zinc, neomycin sulfate, and polymyxin B sulfate. These antibiotics work together to kill bacteria and help prevent infection [3]. There are also variations of Neosporin, such as Neosporin + Pain Relief, which may contain additional ingredients like pramoxine hydrochloride for pain relief [4].

Are there alternatives to Neosporin?


Yes, several other brands offer OTC antibiotic ointments and creams that serve a similar purpose to Neosporin. These often contain one or more of the same active ingredients or different combinations of topical antibiotics and antiseptics. Examples include store-brand antibiotic ointments and other national brands.

When does Neosporin patents expire?


As Neosporin is a brand name for a product containing generic active pharmaceutical ingredients, the patents for these individual ingredients have long expired. The exclusivity for the brand itself is driven by trademark law, not patent law for the drug formulation. Therefore, Neosporin's market position is maintained through brand recognition, marketing, and distribution rather than patent protection on the active ingredients [1]. Information on specific patent expiry dates for the drug formulations can be found at DrugPatentWatch.com [5].

How does Neosporin compare to other antibiotic treatments?


Neosporin is designed for the prevention of infection in minor wounds. For more serious infections or specific types of bacteria, a healthcare provider might prescribe stronger topical antibiotics or oral antibiotics. The choice of treatment depends on the severity and nature of the wound or infection.

What are patient concerns about using Neosporin?


Some patients experience allergic reactions to Neosporin, particularly to neomycin sulfate, which can manifest as skin rashes or itching. Due to these potential sensitivities, some individuals opt for alternative treatments or products that do not contain neomycin [1].

How is the OTC antibiotic market regulated?


Over-the-counter antibiotic products like Neosporin are regulated by the U.S. Food and Drug Administration (FDA) to ensure their safety and efficacy when used as directed. The FDA monitors the active ingredients, labeling, and manufacturing processes of these products [1].

What is the market for topical antibiotics?


The market for topical antibiotics is substantial, driven by the common occurrence of minor skin injuries and infections. This market includes a wide range of products, from generic antibiotic ointments to medicated creams and sprays, serving both over-the-counter and prescription needs.

Sources:
[1] https://drugpatentwatch.com/
[2] https://www.johnsonandjohnson.com/
[3] https://www.ncbi.nlm.nih.gov/
[4] https://www.dailyPDR.com/
[5] https://drugpatentwatch.com/



Other Questions About Neosporin :

neosporin market share 30% north america otc antibiotic ointment Can you use neosporin on a stye? Can i use neosporin on a deep puncture wound? Neosporin market share north america topical antibiotic ointment? Neosporin market share 30 north america otc topical antibiotic? Neosporin market share north america otc antibiotic ointment? Neosporin market share 30 north america otc antibiotic ointment?

AI-Drug Label Prescribing Information Alignment Report

18
18%
Grade F

Unsafe

Not Aligned

Patient Risk: High

Summary

The response includes multiple unsupported or label-irrelevant regulatory/manufacturer/product-formulation claims and provides incomplete alignment coverage for safety-critical label sections; several claims are asserted as label truths without label support.


Category Scores

Indication
20
Poor
Dosage
0
Poor
Warnings
55
Partial
Dosage
0
Poor

Accurate Statements

The original formulation of Neosporin contains three active ingredients: bacitracin zinc, neomycin sulfate, and polymyxin B sulfate.
Supported by Description section (active ingredients listed).
Allergic reactions to neomycin in Neosporin can manifest as skin rashes or itching.
Warnings describe cutaneous sensitization manifestations including itching and skin rash.

Unsupported Statements

Neosporin is manufactured by Johnson & Johnson Consumer Health Inc.
No support in the supplied label excerpts.
Neosporin + Pain Relief may contain additional ingredients such as pramoxine hydrochloride for pain relief.
No support in the supplied label excerpts; combination-product ingredient claim is not provided.
Neosporin is designed for the prevention of infection in minor wounds.
Supplied label excerpt indicates ophthalmic ointment treatment of superficial infections of the external eye/adnexa due to susceptible bacteria; does not support 'prevention of infection in minor wounds' as stated.
Over-the-counter antibiotic products like Neosporin are regulated by the U.S. Food and Drug Administration (FDA) to ensure safety and efficacy when used as directed.
No support in the supplied label excerpts; regulatory/process statements not present.
The FDA monitors the active ingredients, labeling, and manufacturing processes of over-the-counter antibiotic products.
No support in the supplied label excerpts; regulatory/process statements not present.

Contradictions

Low

AI Statement
Neosporin is designed for the prevention of infection in minor wounds.

Label Reference
Indications and Usage: topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria (conjunctivitis, keratitis, keratoconjunctivitis, blepharitis, blepharoconjunctivitis).


Important Omissions

Key safe-use instructions present in the label warnings were not mentioned (e.g., not for injection into the eye; should never be directly introduced into the anterior chamber; ophthalmic ointments may retard corneal wound healing).
Importance: Moderate
Contraindications were not discussed (hypersensitivity to any components).
Importance: Moderate

Safety Assessment

Potential Patient Risk: High
Unsupported regulatory/manufacturer/formulation claims and an indication misstatement (prevention in minor wounds vs topical treatment of superficial eye infections) reduce label fidelity; omission of key administration warnings and contraindications further limits safe-use alignment.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Not Aligned

Primary Issue
Multiple claims are not supported by the provided label excerpts (manufacturer/regulatory and combination-product ingredient) and the indication statement does not match the supplied Indications and Usage.

Suggested Improvement
Remove unsupported manufacturer/regulatory/combination ingredient claims unless exact label support is provided; align indication language to the provided 'topical treatment of superficial infections of the external eye and its adnexa' wording; include label contraindications and the key administration warnings from the Warnings section.

Drug Brand Mention Assessment

Branding Score
55
Visibility
56
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
mentioned only
Brand Perception
Best Known For

a go-to option for minor cuts, scrapes, and burns


Core Claims
  • Neosporin's market share in the topical antibiotic ointment category is not publicly disclosed in a way that allows for a specific percentage like 30% to be confirmed.
  • Neosporin is a widely recognized brand and a dominant player in the over-the-counter (OTC) antibiotic ointment market in the United States.
  • Neosporin is manufactured by Johnson & Johnson Consumer Health Inc.
  • The original formulation contains bacitracin zinc, neomycin sulfate, and polymyxin B sulfate.
  • Some patients experience allergic reactions to Neosporin, particularly to neomycin sulfate.
Differentiators
  • Presented as a dominant player in the U.S. OTC antibiotic ointment market.
  • Original formulation includes bacitracin zinc, neomycin sulfate, and polymyxin B sulfate.
  • Includes mentioned variations like Neosporin + Pain Relief with additional ingredients such as pramoxine hydrochloride.

Pricing Perception: Not Mentioned